Zivo Bioscience Inc (ZIVO)

[errata]

premium valuation, perhaps not. But the last time we hit .20 was almost exactly three years ago, and I could see reaching or exceeding that sometime soon, if there's a GRAS announcement. In fact, it looks like the 890K ask has gone away for the moment, and no great surprise that we're above .12 as a result.

The other high was about five years ago when it was in the .40s. I think we could reach that level when and if there is a real licensing deal, or an acquisition. The warrant holders would presumably be more than happy with a 4x return.

So that's the target, which for those buying now at .12 is not a bad proposition.